Rohit Chandwani, M.D. Ph.D.
Complex General Surgical Oncology
< Back to Search Results

Rohit Chandwani, M.D. Ph.D.

Complex General Surgical Oncology

Accepts New Patients
Gender: Male
Language: English
Insurance: 40 accepted  View

Locations and Appointments



  • Surgical Oncology
  • Pancreatic Surgery


  • Bile Duct Cancer
  • Bile Duct Injury
  • Review of Cancer Care
  • Cholangiocarcinoma
  • Gallbladder Cancer
  • Gallbladder Surgery
  • Hepatobiliary Cancer
  • Hepatobiliary Pancreas Disease
  • Hepato-Biliary Surgery
  • Hepatocellular Carcinoma
  • Jaundice
  • Laparoscopic Cholecystectomy
  • Laparoscopic Surgery
  • Liver Cancer
  • Liver Resection
  • Liver Resection Surgery
  • Metastatic Cancer to Liver
  • Metastatic Colorectal Cancer
  • Minimal Access Surgery
  • Minimally Invasive Surgery
  • Neuroendocrine Tumor of Pancreas
  • Pancreas and Biliary Tract Surgery
  • Pancreas Cancer
  • Pancreas Cyst
  • Pancreatic Cancer
  • Pancreatic Cyst
  • Pancreatic Disease
  • Primary Pancreatic Neuroendocrine Tumor
  • Pancreatic Surgery
  • Pancreatic Tumor
  • Pancreatitis
  • Whipple Procedure


Board Certifications

  • Surgery
  • Complex General Surgical Oncology

Clinical & Academic Positions

  • Assistant Attending Surgeon - NewYork-Presbyterian Hospital
  • Assistant Professor of Surgery - Weill Cornell Medical College, Cornell University
  • Assistant Professor of Cell and Developmental Biology - Weill Cornell Medical College, Cornell University

Education & Training

  • Ph.D., The Rockefeller University, 2013
  • M.D., Yale University School of Medicine, 2005
  • A.B., Harvard University, 2001


View Research

Personal Statement

I am an Assistant Professor in the Department of Surgery at NewYork-Presbyterian / Weill Cornell Medicine and a board-certified surgical oncologist. I also am the Principal Investigator of a basic science laboratory studying the epigenetics of pancreatic and liver cancer.

In collaboration with a multidisciplinary team of gastroenterologists, medical oncologists, interventional radiologists, and pathologists, I combine a multimodality approach and my scientific understanding of cancer to deliver expert, compassionate, and individualized patient care. My clinical focus is the care of patients with pancreatic cancer and other pancreatic diseases, as well as those with metastatic colorectal cancer and liver cancer. 


Rohit Chandwani, M.D., Ph.D. is an Assistant Professor in the Department of Surgery at NewYork-Presbyterian / Weill Cornell Medicine. A board-certified surgical oncologist, Dr. Chandwani is a surgeon in the Section of Liver Transplantation & Hepatopancreatobiliary Surgery with a specific clinical focus in pancreatic cancer and metastatic colorectal cancer. He also has significant clinical expertise in the care of patients with pancreatic cysts, pancreatic neuroendocrine tumors, and intrahepatic and extrahepatic cholangiocarcinoma.

Dr. Chandwani received his undergraduate degree from Harvard University in 2001 and earned his medical degree at the Yale University School of Medicine in 2005. He then trained in General Surgery at NewYork-Presbyterian / Columbia University Medical Center and in Complex General Surgical Oncology at Memorial Sloan Kettering Cancer Center, where he served as Chief Fellow for the Department of Surgery.

A surgeon-scientist, Dr. Chandwani is also the Principal Investigator of the Laboratory of Cancer Epigenetics at Weill Cornell Medical College, where he studies the epigenetic dysregulation of pancreatic cancer. Prior to his research at Cornell, Dr. Chandwani earned his Ph.D. from The Rockefeller University in the laboratory of Alexander Tarakhovsky and was a postdoctoral fellow in the laboratory of Steven D. Leach in the David M. Rubinstein Center for Pancreatic Cancer Research at Memorial Sloan Kettering Cancer Center. He has been the recipient of funding from the National Institutes of Health, the American Association for Cancer Research (AACR), and the Pancreatic Cancer Action Network for his ongoing research program into the epigenetic targeting of cancer. More information about his research can be found at


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA - Medicare
  • Aetna - Weill Cornell - POS
  • Aetna-NYP - EPO/POS
  • Affinity Access
  • Affinity Health Plan
  • Amida Care
  • Blue Priority Network
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield - Pathway X
  • Empire Blue Cross/Blue Shield - Pathway X Enhanced
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Empire Blue Cross/Blue Shield HealthPlus
  • Empire Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP) - Medicare
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP)
  • Medicaid
  • Medicare
  • Oxford Health Plans - Metro/Core/Charter
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care - Medicare
  • United Health Care
  • United Health Care - Community Plan
  • VNSNY CHOICE - Medicare
  • WellCare Health Plans

Honors and Awards

Honors and Awards

New York SuperDoctor: an Honor given to 5% of all New York physicians 

News and Media